RNS Number : 1606F
EKF Diagnostics Holdings PLC
20 May 2026
EKF Diagnostics Holdings plc
("EKF" or the "Company")
Long Term Incentive Plan Award
EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, announces that the Board, following the recommendation of the remuneration committee and after consulting its advisers, has today made the following award (the "Award") to Helen Jones (Chief Financial Officer) under the Company's established LTIP that was adopted on 9 September 2025:
Individual
Position
Type of Award
Number of ordinary shares subject to LTIP award
Helen Jones
Chief Financial Officer
LTIP award - nominal cost option
282,353
The Award has a performance period from the grant date to the third anniversary of the grant date and are subject to the following performance criteria.
The Award shall vest on a sliding scale depending on the total percentage growth of Adjusted EBITDA per share over the Performance Period, as follows:
(i)
Growth of 25% or higher: 100% of the Award vests.
(ii)
Between 10% and 25% growth: Vesting shall occur on a straight-line basis between 25% and 100%.
(iii)
10% growth: 25% of the Award vests; or
(iv)
Below 10% growth: 0% of the Award vests.
Jenny Winter, Chair of the Remuneration committee, commented:
"It is important that our newly appointed CFO, Helen, is rewarded such that her performance indicators align with shareholder value creation. I am satisfied that these incentivisation arrangements achieve that objective."
EKF Diagnostics Holdings plc
www.ekfdiagnostics.com
Julian Baines, Executive Chair
Via Walbrook PR
Gavin Jones, Chief Executive Officer
Singer Capital Markets (Nominated Adviser & Broker)
Tel: +44 (0)20 7496 3000
Phil Davies / Patrick Weaver
Walbrook PR Limited
Tel: +44 (0)20 7933 8780 orekf@walbrookpr.com
Paul McManus / Alice Woodings
Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654
About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)
EKF is an AIM-listed global diagnostics business focussed on:
· Point-of-Care analysers in the key areas of Hematology and Diabetes.
· Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates four manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Helen Jones
2
Reason for the notification
a)
Position/status
Chief Financial Officer
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
EKF Diagnostics Holdings plc
b)
LEI
213800DXTF3EAUK1AR05
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of 1 pence each
Identification code
GB0031509804
b)
Nature of the transaction
Grant of options over ordinary shares pursuant to the Company's LTIP
c)
Price(s) and volume(s)
Price(s)
Volume(s)
1p
282,353
d)
Aggregated information
- Aggregated volume
n/a
- Price
e)
Date of the transaction
20 May 2026
f)
Place of the transaction
Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHURONRNWUVUAR
